title: Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.
abstract: The MLL-ELL fusion gene results from the translocation t(11;19)(q23;p13.1) that is associated with de novo and therapy-related acute myeloid leukemia. To study its transforming properties, we retrovirally transduced primary murine hematopoietic progenitors and assessed their growth properties both in vitro and in vivo. MLL-ELL increased the proliferation of myeloid colony-forming cells in methylcellulose cultures upon serial replating, whereas overexpression of ELL alone had no effect. We reconstituted lethally irradiated congenic mice with bone marrow progenitors transduced with MLL-ELL or the control MIE vector encoding the enhanced green fluorescent protein. When the peripheral blood of the mice was analyzed 11-13 weeks postreconstitution, we found that the engraftment of the MLL-ELL-transduced cells was superior to that of the MIE controls. At this time point, the contribution of the donor cells was normally distributed among the myeloid and nonmyeloid compartments. Although all of the MIE animals (n = 10) remained healthy for more than a year, all of the MLL-ELL mice (n = 20) succumbed to monoclonal or pauciclonal acute myeloid leukemias within 100-200 days. The leukemic cells were readily transplantable to secondary recipients and could be established as immortalized cell lines in liquid cultures. These studies demonstrate the enhancing effect of MLL-ELL on the proliferative potential of myeloid progenitors as well as its causal role in the genesis of acute myeloid leukemias.
authors.affiliation: Systemix Inc., 3155 Porter Drive, Palo Alto, CA 94304, USA.
authors.forename: C
authors.initials: C
authors.lastname: Lavau
authors.forename: R T
authors.initials: RT
authors.lastname: Luo
authors.forename: C
authors.initials: C
authors.lastname: Du
authors.forename: M J
authors.initials: MJ
authors.lastname: Thirman
mesh_terms: D000208:Acute Disease; D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics*; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D006412:Hematopoietic Stem Cells / Q000473:pathology* / Q000502:physiology*; D011495:Histone-Lysine N-Methyltransferase; D007951:Leukemia, Myeloid / Q000209:etiology / Q000235:genetics* / Q000473:pathology*; D051379:Mice; D051788:Myeloid-Lymphoid Leukemia Protein; D009363:Neoplasm Proteins; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D010445:Peptide Elongation Factors; D011519:Proto-Oncogenes; D012190:Retroviridae; D014157:Transcription Factors / Q000235:genetics*; D035602:Transcriptional Elongation Factors
chemical_list: D004268:DNA-Binding Proteins; C090862:ELL protein, human; D009363:Neoplasm Proteins; D015514:Oncogene Proteins, Fusion; D010445:Peptide Elongation Factors; D014157:Transcription Factors; D035602:Transcriptional Elongation Factors; D051788:Myeloid-Lymphoid Leukemia Protein; D011495:Histone-Lysine N-Methyltransferase; C497423:Kmt2a protein, mouse